Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation
Autor: | Rachael N. McVicar, Alicia M. Winquist, Evan Y. Snyder, Sandra L Leibel, Walter D. Niles |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Patient-Specific Modeling ciliated cells Cellular differentiation lung organoid Human Embryonic Stem Cells Cell Culture Techniques smooth muscle 0302 clinical medicine Protocol human pluripotent stem cells Induced pluripotent stem cell Lung Respiratory Tract Infections pulmonary disease modeling Cell Differentiation General Medicine differentiation respiratory system Cell biology Organoids medicine.anatomical_structure Endoderm Ls30 Coronavirus Infections Cell type surfactant Induced Pluripotent Stem Cells Pneumonia Viral Biology Models Biological Time-Lapse Imaging 03 medical and health sciences Betacoronavirus medicine Humans Ls40 Progenitor cell endoderm Pandemics lung development SARS-CoV-2 Mesenchymal stem cell COVID-19 type 2 alveolar cells Cell Biology SARS‐CoV‐2 viral infection Embryonic stem cell Ls90 030104 developmental biology Cell culture 030217 neurology & neurosurgery Developmental Biology type 1 alveolar cells |
Zdroj: | Current Protocols in Stem Cell Biology |
ISSN: | 1938-8969 |
Popis: | The normal development of the pulmonary system is critical to transitioning from placental‐dependent fetal life to alveolar‐dependent newborn life. Human lung development and disease have been difficult to study due to the lack of an in vitro model system containing cells from the large airways and distal alveolus. This article describes a system that allows human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to differentiate and form three‐dimensional (3D) structures that emulate the development, cytoarchitecture, and function of the lung (“organoids”), containing epithelial and mesenchymal cell populations, and including the production of surfactant and presence of ciliated cells. The organoids can also be invested with mesoderm derivatives, differentiated from the same human pluripotent stem cells, such as alveolar macrophages and vasculature. Such lung organoids may be used to study the impact of environmental modifiers and perturbagens (toxins, microbial or viral pathogens, alterations in microbiome) or the efficacy and safety of drugs, biologics, and gene transfer. © 2020 Wiley Periodicals LLC. Basic Protocol: hESC/hiPSC dissection, definitive endoderm formation, and lung progenitor cell induction |
Databáze: | OpenAIRE |
Externí odkaz: |